GILD vs SMXT · P/E 18, rev $7.80B vs rev $91.0M
Gilead Sciences Inc (GILD) versus Solarmax Technology Inc. Common Stock (SMXT) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Solarmax Technology Inc. Common Stock (SMXT) is a solar company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported SMXT revenue for 2025-12-31 was $91.0M. Net income was -$6.3M. Revenue was up 295.8% from 2024-12-31 to 2025-12-31. SMXT currently screens at market cap $23.2M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. SMXT currently screens at market cap $23.2M.
Not investment advice. Open the GILD and SMXT stock pages for the full models.
Not investment advice.